Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Bundang Seongnam, Gyeonggi, Korea.
Gynecol Obstet Invest. 2010;70(1):47-54. doi: 10.1159/000286379. Epub 2010 Feb 19.
BACKGROUND/AIM: The aim of this meta-analysis was to evaluate whether IV albumin infusion around the time of oocyte retrieval prevents ovarian hyperstimulation syndrome (OHSS) and affects the pregnancy rate.
A meta-analysis of data from 9 randomized controlled trials including 1,613 women at high risk for developing OHSS in in vitro fertilization cycles was performed.
The combined incidence of severe OHSS was 6.0% in the IV albumin group and 7.9% in saline or no treatment groups. These rates were statistically not different (RR = 0.80, 95% CI = 0.57-1.12). Treatment with IV albumin significantly lowered the pregnancy rates (RR = 0.85, 95% CI = 0.74-0.98).
The combined data presented in this meta-analysis do not support a benefit for IV albumin around the time of oocyte retrieval in preventing OHSS and even showed a deleterious effect on the pregnancy rate.
背景/目的:本荟萃分析旨在评估在取卵时输注静脉白蛋白是否可以预防卵巢过度刺激综合征(OHSS)并影响妊娠率。
对 9 项随机对照试验的数据进行荟萃分析,这些试验共纳入了 1613 名在体外受精周期中存在发生 OHSS 高风险的妇女。
静脉白蛋白组严重 OHSS 的综合发生率为 6.0%,生理盐水或未治疗组为 7.9%。这些发生率在统计学上没有差异(RR = 0.80,95% CI = 0.57-1.12)。静脉白蛋白治疗显著降低了妊娠率(RR = 0.85,95% CI = 0.74-0.98)。
本荟萃分析中呈现的综合数据不支持在取卵时输注静脉白蛋白预防 OHSS 的益处,甚至对妊娠率显示出有害影响。